Data#3
↗Brisbane, Australia
Data#3 Limited is a leading Australian IT services and solutions provider that delivers a wide range of technology solutions to various sectors, including healthcare, government, and education. The company specializes in cloud services, cybersecurity, digital infrastructure, and modern workplace solutions, helping organizations leverage technology to improve operational efficiency and data management.
While not a pharmaceutical manufacturer, Data#3 is a critical technology partner for the pharmaceutical and life sciences industries in the Asia-Pacific region. They provide the underlying digital infrastructure, secure data storage, and compliance-ready cloud environments necessary for research, clinical data management, and pharmaceutical supply chain operations. Their expertise lies in integrating complex IT systems and ensuring data integrity and security for highly regulated industries.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:IT Services and Infrastructure
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$2.5B - $3.0B AUD
Founded:1977
Ownership:public
Status:operating
FUNDING
Stage:Pre-IPO
STOCK
Exchange:ASX
Ticker:DTL
Market Cap:$1.35B AUD
0
CORPORATE STRUCTURE
Subsidiaries:Business Aspect, Discovery Technology
Key Partnerships:Microsoft (Gold Partner), Cisco (Gold Partner), HP, Dell Technologies, Adobe, Veeam
COMPETITION
Position:Leader
Competitors:Brennan IT, Telstra Purple, DXC Technology, Insight Enterprises, Kinly
LEADERSHIP
Key Executives:
Brad Munchow - Chief Executive Officer & Managing Director
Cherie O'Riordan - Chief Financial Officer
Board Members:Mark Gray (Chairman), Susan Forrester, Mark Esler, Leanne Muller
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Data#3. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.